Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 13, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • patients
  • Page 2

Tag: patients

  • BiotechToday
  • World

When machine-learning takes over healthcare in studying respiratory behaviors

bioxone November 10, 2020November 10, 2020 1

-Camelia Bhattacharyya, Amity University Kolkata Dave Waters once said, “A baby learns to crawl, walk and then run. We are in the crawling stage when it comes to applying machine learning”. This professor or scientist and researcher also said, “Machine learning will automate jobs that most people thought could only be done by people”. The […]

Read More
  • BiotechToday
  • India

PLASMA THERAPY – DEAD END FOR COVID-19?

bioxone October 29, 2020October 29, 2020 2

Aishila Kar, Amity University Kolkata In New Delhi, since ILBS Hospital, initiates its plasma bank from July, requests have poured in continuously. Jai Prakash said that when someone close to you is about to die, you will take whatever form of hope you can find, age of 44, who obtained plasma last month for his […]

Read More
  • BiotechToday
  • World

Is the pandemic interfering with the treatment for other diseases?

bioxone October 19, 2020October 19, 2020

Camelia Bhattacharyya, Amity University Kolkata The pandemic, that is, the COVID-19 pandemic hit the world all of a sudden, changing infection rates or rather increasing it every day without leaving the world to think of the ways to fight with the unknown enemy, the virus. This created a lot of panic at the beginning of […]

Read More
  • BiotechToday
  • World

Is the frequent prescription of PPI medicines a boon or a bane?

bioxone October 18, 2020October 18, 2020 4

Husna, Amity University Kolkata Proton pump inhibitors (PPIs) are a class of medicines that work on the cells which are lining the stomach, reducing the production of acid in our stomach. They can treat heartburn and gastric acid reflux by irreversibly binding with the Na+ H+ ATPase located on the surface of gastric parietal cells.PPIs […]

Read More
  • BiotechToday
  • World

VISCERAL METASTASIS MECHANISM PROVED ESSENTIAL FOR CRPC PATIENTS

bioxone October 17, 2020October 17, 2020

Aishila Kar,Amity University Kolkata An important poor prognostic factor of prostate cancer (PC), visceral metastasis (VM), is not commonly observed in castration sensitive progression but continuously seen after castration-resistant progression. Still, the site, timing of appearance, and incidence of VM in castration-resistant patients have not yet been fully explained.  At Kanazawa University Hospital, demographic, surgical, […]

Read More
  • BiotechToday
  • India

SIGN TO START PHASE 1 HUMAN TRIAL OF “ANTISERA”-DCGI

bioxone October 7, 2020October 7, 2020

Aishila Kar, Amity University Kolkata ICMR officials said on Tuesday that The Drugs Controller General of India has given authorization for conducting Phase-1 human clinical trial for an “antisera” that was developed by injecting inactivated SARS-CoV-2 in horses and can be a treatment for COVID-19. The Indian Council of Medical Research (ICMR) in alliance with a Hyderabad-based vaccine maker […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy